BC
CERE
Brookfield Corp’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-43,204
| Closed | -$1.28M | – | 737 |
|
|
2021
Q3 | $1.28M | Buy |
43,204
+13,690
| +46% | +$404K | 0.01% | 393 |
|
|
2021
Q2 | $756K | Buy |
29,514
+5,261
| +22% | +$135K | ﹤0.01% | 475 |
|
|
2021
Q1 | $333K | Sell |
24,253
-12,102
| -33% | -$166K | ﹤0.01% | 427 |
|
|
2020
Q4 | $603K | Buy |
+36,355
| New | +$603K | ﹤0.01% | 399 |
|